Skip to main content

Resmed Inc(RMD-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low248.13
Day High253.26
Open:253.15
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Resmed Inc

Select a category then submit the form to load news
GlobeNewswire
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
ACCESS Newswire
Richmond Commences Drilling Program at Aguara East
GlobeNewswire
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
StockStory
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?
RMD
Tipranks
ResMed Tests Smart CPAP Pressure Tool in New Sleep Apnea Trial
StockStory
3 Quality Compounders to Consider Right Now
FIX
Zacks Investment Research
Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial
Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial
Zacks Investment Research
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Zacks Investment Research
ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down
ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down
Tipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from UBS
StockStory
The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call
RMD
Tipranks
Morgan Stanley Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
Tipranks
Goldman Sachs Reaffirms Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
Zacks Investment Research
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
Tipranks
Ord Minnett Sticks to Its Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
Tipranks
Positive Report for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) from Morgans
Tipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Gets a Buy from Macquarie
Tipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Citi
Zacks Investment Research
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
Tipranks
ResMed Reaffirms 2025 Risk Profile: No Material Changes to Previously Disclosed Threats
Tipranks
ResMed Inc Earnings Call Shows Profitable Growth Momentum
Tipranks
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Canaccord Genuity
Tipranks
Analysts Conflicted on These Healthcare Names: Resmed (RMD), Radiopharm Theranostics Limited Sponsored ADR (RADX) and Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX) and Resmed (RMD)
Tipranks
Analysts’ Top Healthcare Picks: Regeneron (REGN), Resmed (RMD)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), Resmed (RMD) and Sanofi (OtherSNYNF)
Tipranks
Resmed (RMD) Receives a Hold from Stifel Nicolaus
Tipranks
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), NewAmsterdam Pharma Company (NAMS) and Resmed (RMD)
Tipranks
RBC Capital Reaffirms Their Buy Rating on Resmed (RMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Resmed (RMD)
Tipranks
Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Waters (WAT) and Teva Pharmaceutical (TEVA)
Tipranks
ResMed Announces Dividend and Strong Quarterly Earnings Growth

Profile

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.